Cleared Traditional

K072666 - BIOARTERIAL PLUS, ARTERIAL BLOOD FLOW ENHANCEMENT SYSTEM

K072666 is an FDA 510(k) clearance for BIOARTERIAL PLUS, manufactured by Bio Compression Systems, Inc.. The device is a Class 2 Cardiovascular device with product code JOW cleared through the Traditional 510(k) pathway after a 45-day FDA review.

K072666 · Bio Compression Systems, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2007
Decision
45d
Days
Class 2
Risk

K072666 is an FDA 510(k) clearance for the BIOARTERIAL PLUS, ARTERIAL BLOOD FLOW ENHANCEMENT SYSTEM. Classified as Sleeve, Limb, Compressible (product code JOW), Class II - Special Controls.

Submitted by Bio Compression Systems, Inc. (Broadview Heights, US). The FDA issued a Cleared decision on November 5, 2007 after a review of 45 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.5800 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Bio Compression Systems, Inc. devices

FDA 510(k) Submission Details - K072666

510(k) Number K072666 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 21, 2007
Decision Date November 05, 2007
Days to Decision 45 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
80d faster than avg
Panel avg: 125d · This submission: 45d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

JOW Device Classification - Class 2, Special Controls

Product Code JOW Sleeve, Limb, Compressible
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.5800
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Intertek Testing Services
DANIEL W LEHTONEN

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - JOW Sleeve, Limb, Compressible

All 316
Devices cleared under the same product code (JOW) and FDA review panel - the closest regulatory comparables to K072666.
VENOWAVE MODELS VW5-6, VW5-10, VW5-20 AND VW5-30
K073028 · Venowave, Inc. · Mar 2008
PHLEBOPRESS MODEL 601A COMPRESSION THERAPY DEVICE
K072372 · Mego Afek · Nov 2007
CTU676 DEVICE
K073013 · Compression Technologies Unlimited, Inc. · Nov 2007
AVIAFIT PULSATING LEGBAND
K071744 · Flowmedic , Ltd. · Sep 2007
WRIGHT MODEL 51 AND 52 SEQUENTIAL COMPRESSION SYSTEMS
K071040 · Wright Linear Pump, Inc. · May 2007
IPC-BOOT
K070324 · C-Boot , Ltd. · May 2007